Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M J, Sheardown"'
Autor:
David R. Adams, C.S. Malcolm, Richard Porter, D F Revell, H Lamb, N H Allen, M J Sheardown, K Benwell
Publikováno v:
British Journal of Pharmacology. 128:13-20
1. The goal of this study was to characterize the agonist pharmacology of human 5-HT2A, 5-HT2B and 5-HT2C (VSV) receptors expressed in CHO-K1 (Chinese hamster ovary) cells. 2. We used a fluorometric imaging plate reader (FLIPR) which allows rapid det
Publikováno v:
Journal of Cerebral Blood Flow & Metabolism. 13:183-192
Brain trauma is associated with acute functional impairment and neuronal injury. At present, it is unclear to what extent disturbances in ion homeostasis are involved in these changes. We used ion-selective microelectrodes to register interstitial po
Autor:
K J, Stanhope, N R, Mirza, M J, Bickerdike, J L, Bright, N R, Harrington, M B, Hesselink, G A, Kennett, S, Lightowler, M J, Sheardown, R, Syed, R L, Upton, G, Wadsworth, S M, Weiss, A, Wyatt
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 299(2)
The muscarinic receptor agonist xanomeline was examined and compared with the antipsychotics clozapine and/or haloperidol in the following in vivo rat models: apomorphine-induced disruption of prepulse inhibition (PPI), amphetamine-induced hyperlocom
Publikováno v:
Biochemical pharmacology. 62(4)
The desensitization characteristics of recombinant human 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptors (VSV and INI isoforms) stably expressed in CHO-K1 (Chinese hamster ovary) cells was investigated by calcium fluorimetry. Comparative desensitization c
Autor:
R H, Porter, K R, Benwell, H, Lamb, C S, Malcolm, N H, Allen, D F, Revell, D R, Adams, M J, Sheardown
Publikováno v:
British journal of pharmacology. 128(1)
1. The goal of this study was to characterize the agonist pharmacology of human 5-HT2A, 5-HT2B and 5-HT2C (VSV) receptors expressed in CHO-K1 (Chinese hamster ovary) cells. 2. We used a fluorometric imaging plate reader (FLIPR) which allows rapid det
Autor:
M J, Sheardown, H E, Shannon, M D, Swedberg, P D, Suzdak, F P, Bymaster, P H, Olesen, C H, Mitch, J S, Ward, P, Sauerberg
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 281(2)
The analgesic effects of a series of muscarinic agonists were investigated by use of the mouse acetic acid writhing, grid-shock, hot-plate and tail-flick tests. The compounds tested were oxotremorine, pilocarpine, arecoline, aceclidine, RS86 and four
Autor:
M D, Swedberg, M J, Sheardown, P, Sauerberg, P H, Olesen, P D, Suzdak, K T, Hansen, F P, Bymaster, J S, Ward, C H, Mitch, D O, Calligaro, N W, Delapp, H E, Shannon
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 281(2)
Butylthio[2.2.2] ((+)-(S)-3-(4-(Butylthio)-1,2,5-thiadiazol-3-yl)-1-azabicyclo[2.2. 2] octane) is an agonist/antagonist at muscarinic receptors. The analgesic potential of butylthio[2.2.2] was assessed in the mouse by use of the grid-shock, tail-flic
Autor:
H E, Shannon, M J, Sheardown, F P, Bymaster, D O, Calligaro, N W, Delapp, J, Gidda, C H, Mitch, B D, Sawyer, P W, Stengel, J S, Ward, D T, Wong, P H, Olesen, P D, Suzdak, P, Sauerberg, M D, Swedberg
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 281(2)
Butylthio[2.2.2], ((+)-(S)-3-(4-butylthio-1,2,5-thiadiazol-3-yl)-1-azabicyclo[2.2.2] octane; LY297802/NNC11-1053) is a muscarinic receptor ligand which is equiefficacious to morphine in producing antinociception. In vitro, butylthio[2.2.2] had high a
Autor:
C. H. Mitch, F. P. Bymaster, D. O. Calligaro, S. J. Quimby, B. D. Sawyer, H. E. Shannon, J. S. Ward, P. H. Olesen, P. Sauerberg, M. J. Sheardown, P. D. Suzdak, Novo Nordisk
Publikováno v:
Alzheimer’s and Parkinson’s Diseases ISBN: 9781475791471
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01a4252f01f408f12e8bd1dde0525080
https://doi.org/10.1007/978-1-4757-9145-7_66
https://doi.org/10.1007/978-1-4757-9145-7_66
Autor:
F P, Bymaster, D T, Wong, C H, Mitch, J S, Ward, D O, Calligaro, D D, Schoepp, H E, Shannon, M J, Sheardown, P H, Olesen, P D, Suzdak, M D, Swedberg, P, Sauerberg
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 269(1)
Xanomeline [3(3-hexyloxy-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-me thylpyridine)] was evaluated in vivo in rat brain for effects on neurotransmitter turnover and inhibition of ex vivo binding of muscarinic radioligands. Xanomeline produced dose-